{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:15:49Z","timestamp":1780442149411,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jacep.2018.01.007","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T16:12:34Z","timestamp":1522253554000},"page":"660-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy"],"prefix":"10.1016","volume":"4","author":[{"given":"Kathryn","family":"Coyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratika","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence D.","family":"Sterns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidal","family":"Essebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Hruczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Blier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.L.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Sapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2018.01.007_bib1","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1001\/jama.288.23.3008","article-title":"Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000","volume":"288","author":"Cobb","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2018.01.007_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.pcad.2008.06.003","article-title":"Epidemiology of sudden cardiac death: clinical and research implications","volume":"51","author":"Chugh","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacep.2018.01.007_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"Epstein","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2018.01.007_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2018.01.007_bib5","first-page":"315","article-title":"Optimisation versus certainty: understanding the issue of heterogeneity in economic evaluation","volume":"58","author":"Stevens","year":"2004","journal-title":"Soc SCI: Med"},{"key":"10.1016\/j.jacep.2018.01.007_bib6","unstructured":"Canadian Coordinating Office for Health Technology Assessment. Guidelines for the Economic Evaluation of Health Technologies: Canada. 4th edition. 2017. Available at: https:\/\/www.cadth.ca\/guidelines-economic-evaluation-health-technologies-canada-4th-edition. Accessed April 7, 2017."},{"key":"10.1016\/j.jacep.2018.01.007_bib7","unstructured":"Ontario Ministry of Health and Long Term Care, Ontario Drug Benefit Formulary \/ Comparative Drug Index. 2016. Available at: http:\/\/www.health.gov.on.ca\/en\/. Accessed September 30, 2016."},{"key":"10.1016\/j.jacep.2018.01.007_bib8","unstructured":"Ontario Ministry of Health and Long Term Care. Schedule of Benefits for Physician Services Under the Health Insurance Act. 2016. Available at: http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/ohip\/sob\/physserv\/sob_master20160401.pdf. Accessed October 1,\u00a02016."},{"key":"10.1016\/j.jacep.2018.01.007_bib9","unstructured":"Ontario Ministry of Health and Long Term Care. Ontario Case Costing Initiative. OCC Costing Analysis Tool. 2016. Available at: https:\/\/stage\/hsim\/health.gov.on.ca\/hdbportal. Accessed October 6, 2017."},{"key":"10.1016\/j.jacep.2018.01.007_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.12927\/hcq.2009.20411","article-title":"CIHI Survey: ED spending in Canada: a focus on the cost of patients waiting for access to an in-patient bed in Ontario","volume":"12","author":"Dawson","year":"2009","journal-title":"Healthc Q"},{"key":"10.1016\/j.jacep.2018.01.007_bib11","unstructured":"Ontario Public Drug Programs Ministry of Health and Long-Term Care. Regulation Amendments in Support of Sustainability and Access for the Ontario Drug Benefit Program. 2015. Available\u00a0at: http:\/\/www.health.gov.on.ca\/en\/pro\/programs\/drugs\/opdp_eo\/notices\/fq_exec_office_20150917_1.pdf. Accessed October 1,\u00a02016."},{"key":"10.1016\/j.jacep.2018.01.007_bib12","unstructured":"Ontario Ministry of Health and Long Term Care. Ontario Drug Benefit Program: Dispensing Fees. 2014. Available at: http:\/\/www.health.gov.on.ca\/en\/public\/programs\/drugs\/programs\/odb\/opdp_dispensing_fees.aspx. Accessed September 30, 2016."},{"key":"10.1016\/j.jacep.2018.01.007_bib13","unstructured":"Bank of Canada Inflation Calculator. 2015. Available at: http:\/\/www.bankofcanada.ca\/rates\/related\/inflation-calculator\/. Accessed September 25,\u00a02016."},{"key":"10.1016\/j.jacep.2018.01.007_bib14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol\u00a0health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"10.1016\/j.jacep.2018.01.007_bib15","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","article-title":"A\u00a0guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials","volume":"32","author":"Faria","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jacep.2018.01.007_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/qjmed\/92.3.177","article-title":"Bootstrapping: estimating confidence intervals for cost-effectiveness ratios","volume":"92","author":"Campbell","year":"1999","journal-title":"QJM"},{"key":"10.1016\/j.jacep.2018.01.007_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/01.CIR.101.3.280","article-title":"Cost-effectiveness of catheter ablation in patients with ventricular tachycardia","volume":"101","author":"Calkins","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2018.01.007_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/bmb\/ldr001","article-title":"Health outcomes in economic evaluation: who should value health?","volume":"97","author":"Stamuli","year":"2011","journal-title":"Br Med Bull"},{"key":"10.1016\/j.jacep.2018.01.007_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hec.788","article-title":"Stratified\u00a0cost-effectiveness analysis: a framework for establishing efficient limited\u00a0use\u00a0criteria","volume":"12","author":"Coyle","year":"2003","journal-title":"Health Econ"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X18300689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X18300689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:26:16Z","timestamp":1762500376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X18300689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2405500X18300689"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2018.01.007","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2018.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}